´ëÇÑÀ忬±¸ÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-16±³À°ÀÏÀÚ : 2020-12-16
±³À°Àå¼Ò : º¤½ºÄÚ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis ÁÖÃÖ±â°ü : ´ëÇÑÀ忬±¸ÇÐȸ
´ã´çÀÚ : ±èº¸¶÷
¿¬¶ôó : 02-957-6145
À̸ÞÀÏ :
thekasid2@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í AOCC Member US$ 30/ Non-Member US$ 40/Trainee , Resident, Nurse, Pharmacist, Researcher, Exhibitor US$ 20
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 09:30~10:00 Targeting success – A tight disease control strategy in IBD Edward V. Loftus Jr.(Mayo Clinic)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:00~10:30 Targeting success – A tight disease control strategy in IBD Taku Kobayashi(Kitasato University Kitasato Institute Hospital)
ÈÞ½Ä 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:30~10:50 ÈÞ½Ä ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 10:50~11:10 Epidemiological trends of IBD: What is new? Siew Chien Ng(The Chinese University of Hong Kong)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:10~11:30 Diagnostic challenges of IBD: How to differentiate IBD mimics? Zhihua Ran(Shanghai Jiao-Tong University School of Medicine)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:30~11:50 Smart use of thiopurine and anti-TNF: What should we know? Tadakazu Hisamatsu(Kyorin University)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 11:50~12:05 ±¸¿¬¹ßÇ¥ Abstract(Abstract)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:05~12:20 ±¸¿¬¹ßÇ¥ Abstract(Abstract)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:20~12:50 Why sequencing matters? Katsuyoshi Matsuoka(Toho University Sakura Medical Center)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 12:50~13:20 Which therapy and when? Brian L Bressler(University of British Columbia)
ÈÞ½Ä 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 13:20~13:40 ÈÞ½Ä ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 13:40~14:00 Good bugs and bad bugs in colitis and colitis-associated cancer Christian Jobin(University of Florida)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:00~14:20 Viruses and fungi in the pathogenic and therapeutic perspectives Takayuki Imai(Shiga University of Medical Science)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:20~14:40 FMT: Where are we now and where are we going? Young-Seok Cho(The Catholic University of Korea)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 14:40~15:00 The future of microbiome engineering for IBD treatment Harry Sokol(Saint-Antoine Hospital)
Åä·Ð 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:00~15:10 Discussion ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ)
ÈÞ½Ä 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:10~15:20 ÈÞ½Ä ¸ðµçÂü°¡ÀÚ(¸ðµçÂü°¡ÀÚ)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:30~15:45 Part 1. Small bowel CDIdentification of stricture characteristic using cross sectional images: inflammatory vs fibrotic Se Hyung Kim(Seoul National University)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 15:45~16:00 Part 1. Small bowel CDNonsurgical therapies: drugs and balloon Takayuki Matsumoto(Iwate Medical University)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:00~16:15 Part 1. Small bowel CDSurgical treatment: optimal timing, preparation, and technique Willem A. Bemelman(Amsterdam University Medical Centers)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:15~16:30 Part 2. Acute severe UCOptimal strategies for drug therapy: Which one, when, and how? Hiroshi Nakase(Sapporo Medical University)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:30~16:45 Part 2. Acute severe UCReview of outcome predictors: prognosticators and available indices Silvio Danese(Humanitas Research Hospital)
±³À°½Ã°£ 12¿ù 16ÀÏ BEXCO, ÄÁº¥¼ÇȦ 205È£ 16:45~17:00 Part 2. Acute severe UCState of the art for surgical treatment Kyu Joo Park(Seoul National University)